# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-010387
Filing Date
2021-05-14
Accepted
2021-05-14 17:14:40
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20210331.htm iXBRL | 10-Q | 772949
2 | EX-31.1 | a2021q1-exhibit311.htm | EX-31.1 | 12642
3 | EX-31.2 | a2021q1-exhibit312.htm | EX-31.2 | 12651
4 | EX-32.1 | a2021q1-exhibit321.htm | EX-32.1 | 6985
| Complete submission text file | 0001628280-21-010387.txt |  | 3740307

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20210331.xsd | EX-101.SCH | 27240
6 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20210331_cal.xml | EX-101.CAL | 64144
7 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20210331_def.xml | EX-101.DEF | 110449
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20210331_lab.xml | EX-101.LAB | 354127
9 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20210331_pre.xml | EX-101.PRE | 230920
10 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20210331_htm.xml | XML | 475317

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 21925968
SIC: 2834 Pharmaceutical Preparations